We are live on ! Find out more
LICN icon

Lichen China
LICN

6 hedge funds and large institutions have $445K invested in Lichen China in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $422K → $445K (+$22.7K)

0.16% less ownership

Funds ownership: 1.01% → 0.86% (-0.16%)

14% less funds holding

Funds holding: 7 → 6 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$4.62K
2
HF
HRT Financial
New York
+$1.92K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$24.6K
2
VF
Virtu Financial
New York
-$20K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$19.8K
4
UBS Group
UBS Group
Switzerland
-$14.6K
5
XT
XTX Topco
Cayman Islands
-$1.16K

LICN Hedge Fund Activity: Q3 2024 in Review

6 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q3 2024, worth a combined $445K — up 5.4% from $422K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of LICN and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $4.62K. The largest seller was Citadel Advisors, cutting an estimated $24.6K.

  • 6 institutional investors held Lichen China (LICN) as of Q3 2024, down from 7 in Q2 2024.
  • Funds reported $445K of Lichen China stock for Q3 2024, up 5.4% quarter-over-quarter.
  • 1 fund opened new Lichen China positions in Q3 2024 and 2 closed out, a net change of -1 holder.
  • The largest Lichen China buyer in Q3 2024 was Tower Research Capital (TRC), an estimated $4.62K added.
  • The largest Lichen China seller in Q3 2024 was Citadel Advisors, an estimated $24.6K sold.

Based on aggregated 13F filings for Q3 2024.